Cargando…
Recent policies that support clinical application of induced pluripotent stem cell-based regenerative therapies
In Japan, a research center network consisting of Kyoto University to provide clinical-grade induced Pluripotent Stem Cells (iPSC) and several major research centers to develop iPSC-based regenerative therapies was formed for the clinical application of iPSCs. This network is under the supervision o...
Autores principales: | Azuma, Kentaro, Yamanaka, Shinya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society for Regenerative Medicine
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581825/ https://www.ncbi.nlm.nih.gov/pubmed/31245486 http://dx.doi.org/10.1016/j.reth.2016.01.009 |
Ejemplares similares
-
Pluripotent stem cell-based therapies and their path to the clinic
por: Takayama, Kazuo, et al.
Publicado: (2023) -
Recent technological updates and clinical applications of induced pluripotent stem cells
por: Diecke, Sebastian, et al.
Publicado: (2014) -
Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery
por: Singh, Vimal K., et al.
Publicado: (2015) -
Characterization of induced pluripotent stem cell‐derived megakaryocyte lysates for potential regenerative applications
por: Baigger, Anja, et al.
Publicado: (2018) -
Bringing Induced Pluripotent Stem Cell Technology to the Bedside
por: Karagiannis, Peter, et al.
Publicado: (2018)